Gossamer Bio Inc. (GOSS) Misses Q3 EPS by 2c; Reports Cash and Cash Equivalents of $366.0M
Gossamer Bio Inc. (NASDAQ: GOSS) reported Q3 EPS of ($0.80), $0.02 worse than the analyst estimate of ($0.78).
For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.